Antidiabetic Effects of the Senolytic Agent Dasatinib.

•  
• Overview
•  
• Identity
•  
• Additional Document Info
•  
• View All
•  

Overview

authors

• Salaami, Omid
• Kuo, Chia-Ling
• Drake, Matthew T
• George A. Kuchel, MD, FRCP, AGSF
• Kirkland, James L
• Pignolo, Robert J

publication date

• January 1, 2021

published in

• Mayo Clinic proceedings  Journal

has subject area

• Blood Glucose
• Dasatinib
• Diabetes Mellitus, Type 2
• Female
• Glycated Hemoglobin
• Glycemic Control
• Humans
• Hypoglycemic Agents
• Imatinib Mesylate
• Linear Models
• Male
• Middle Aged
• Retrospective Studies
• Senotherapeutics

Identity

Digital Object Identifier (DOI)

• https://doi.org/10.1016/j.mayocp.2021.06.025

PubMed ID

• 34772496

Additional Document Info

start page

• 3021

end page

• 3029

volume

• 96

issue

• 12